Chemistry Ventures, a venture capital firm launched two years ago by alumni from Andreessen Horowitz (a16z), Bessemer, and Index Ventures, is raising $500 million for its second fund to back early-stage AI startups. The firm, which started with a $350 million initial fund, has already attracted enough investor interest to be oversubscribed, according to an SEC filing and reporting from the Wall Street Journal.

The fundraise represents a significant vote of confidence in the firm's strategy of combining expertise from some of the venture capital industry's largest and most influential firms. Founded by Mark Goldberg, Ethan Kurzweil, and Kristina Shen, Chemistry was created specifically to leverage the trio's collective experience investing in AI infrastructure and applications at their previous firms.

Who Are the Founders and What's Their Track Record?

Each of Chemistry's three co-founders brings deep experience from top-tier venture firms. Goldberg previously worked at Index Ventures, Kurzweil at Bessemer, and Shen at a16z, one of the most active investors in artificial intelligence globally. Their decision to launch Chemistry two years ago reflected a belief that they could operate more effectively as an independent team focused specifically on AI investments.

The firm's first fund has already backed a portfolio of promising early-stage companies working across different layers of the AI stack. These portfolio companies demonstrate the breadth of Chemistry's investment thesis, spanning both the infrastructure that powers AI systems and the consumer and enterprise applications built on top of them.

What Companies Has Chemistry Already Backed?

Chemistry's existing portfolio includes several startups working on different aspects of the AI ecosystem:

• Granola: A company focused on AI-powered productivity and data organization
• Decagon: An AI infrastructure or training-focused startup
• Persona: A platform working on identity verification and compliance
• Serval: An AI infrastructure or deployment-focused company
• Nova Intelligence: A startup building AI applications or tools

This portfolio mix reflects Chemistry's dual focus on both the foundational infrastructure that makes AI systems possible and the practical applications that end users and businesses actually interact with. The diversity of bets suggests the firm is not betting on any single AI trend but rather positioning itself across multiple promising areas.

How to Evaluate VC Firms Focused on AI Investments

For founders and investors tracking the venture capital landscape, several factors distinguish firms like Chemistry from broader venture investors:

• Specialized Expertise: Firms founded by veterans from leading AI-focused investors bring deep knowledge of the technical and business challenges specific to AI startups, not just general startup experience
• Portfolio Diversification: Look for firms investing across multiple layers of the AI stack, from infrastructure to applications, rather than betting heavily on a single category or trend
• Founder Pedigree: Teams drawn from successful large venture firms often bring both capital and operational experience that can help portfolio companies scale faster
• Fund Momentum: Oversubscribed fundraises indicate that limited partners (institutional investors) believe in the firm's track record and thesis, which can signal stronger future performance

Chemistry's second fund being oversubscribed is particularly noteworthy because it suggests that investors are confident in the firm's ability to identify and support promising AI startups. In venture capital, an oversubscribed fund means more investors want to commit capital than the firm is willing to accept, allowing the firm to be selective about its limited partners.

What Does This Mean for the AI Investment Landscape?

The rapid growth of Chemistry Ventures reflects a broader trend in venture capital: the emergence of specialized AI-focused funds founded by experienced operators who previously worked at larger firms. Rather than staying at established venture firms, talented investors are increasingly launching independent vehicles to pursue their own investment theses with more autonomy and focus.

The $500 million second fund also signals that the market for early-stage AI startups remains robust. Despite concerns about AI hype and valuations in some sectors, venture investors continue to see significant opportunity in backing founders building AI infrastructure and applications. Chemistry's ability to raise a larger second fund than its initial $350 million suggests that the firm's first fund performed well enough to attract additional capital.

The fundraise is expected to close soon, according to reporting from the Wall Street Journal, meaning Chemistry will soon have substantial new capital to deploy into the next generation of AI startups. For founders in the AI space, the emergence of specialized firms like Chemistry with deep expertise and significant capital represents both increased competition for funding and access to investors who understand the unique challenges of building AI companies.